LEXOSIRAN
UNII 3UHY5455YT

Substance Identification & Data

This profile provides standardized clinical and technical data for Lexosiran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3UHY5455YT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3078403-66-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3UHY5455YT
CAS Registry Number
3078403-66-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LEXOSIRAN
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13833
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lexosiran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LEXOSIRAN

Common Names & Synonyms

LEXOSIRAN [INN]
RNA, ((1'-DE(6-AMINO-9H-PURIN-9-YL))A-(5'->5')-SP-GM-AM-AM-UM-GM-GM-AM-AM-(2'-DEOXY-2'-FLUORO)G-GM-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)A-UM-AM-CM-UM-CM-UM-AM-AM-(3'->3')-SP-(1'-DE(6-AMINO-9H-PURIN-9-YL))A), 3'-(O-(1-(18-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-6,10-BIS(2-((2-(2-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)ETHOXY)ETHYL)AMINO)-2-OXOETHYL)-1,5,12-TRIOXO-16-OXA-6,10,13-TRIAZAOCTADEC-1-YL)-4-PIPERIDINYL) HYDROGEN PHOSPHOROTHIOATE), COMPLEX WITH RNA (UM-SP-(2'-DEOXY-2'-FLUORO)U-SP-AM-GM-AM-GM-(2'-DEOXY-2'-FLUORO)U-AM-UM-AM-AM-(2'-DEOXY-2'-FLUORO)C-CM-(2'-DEOXY-2'-FLUORO)U-UM-(2'-DEOXY-2'-FLUORO)C-CM-AM-UM-SP-UM-SP-CM) (1:1)